
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About ViewRay
ViewRay Inc. develops radiation therapy technology for the treatment of cancer. The Company offers radiation therapy systems that images and treats cancer patients simultaneously. ViewRay serves customers worldwide.
Stock Analysis

last close
$3.79
1-mo return
30.7%
3-mo return
20.7%
avg daily vol.
848.76T
52-week high
8.25
52-week low
2.39
market cap.
$672M
forward pe
-
annual div.
-
roe
-80.1%
ltg forecast
-
dividend yield
-
annual rev.
$81M
inst own.
90.1%